Intellia Therapeutics, Inc. · NASDAQ:NTLA

Cohen Fred E received 9,200 Intellia Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 9, 2026 · Filed Jun 10, 2026

On Jun 9, 2026, Cohen Fred E (Director) received 9,200 Intellia Therapeutics, Inc. shares as an award, leaving 216,653 shares. Filed Jun 10, 2026 (Form 4).

Awarded
9,200 shares
Holding after
216,653 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 9, 2026Common StockAward9,200216,653Direct

Source

View original at SEC

Related